Egypt’s Contraceptives market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Govt. of Egypt is committed to safeguarding the health of women and girls in the country and mitigating the rate of its population growth by expanding its contraceptive programs and improving the quality of services to attract new users while expanding contraceptive methods choice. Accordingly, the Strategic National Population Plan 2015-2030 in Egypt has called for accelerated efforts to reduce the TFR to 2.4 births per woman by the year 2030. Theoretically, such a fertility level can be achieved by increasing contraceptive prevalence from 58% in 2014 to 72%, thus increasing the demand for the market in the forecast period.
Social, cultural, and religious norms in Egypt have sometimes caused family planning to be stigmatized.
Market Drivers
With the rapid growth of the Egyptian population from 20.8 to 100 million inhabitants in the past 50 years, strenuous efforts have been made to promote maternal and child health through family planning programs that empower families to make informed decisions on the number of children and interval between children they want and to reduce unintended pregnancies. This will continue to boost the market for contraceptives in Egypt.
Rising rates of STDs have made people aware of contraceptives and the market is expected to sustain and grow through the forecast period.
Misconceptions about contraceptives still exist and this could factor in restraining the market growth in the country.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt’s OTC drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Over-the-counter drugs are sold to the customer without a prescription from the doctor. They are typically used for minor health problems and are available at local pharmacies and shops. They are safe and effective when consumed according to the physician’s directions. OTC drugs can be readily available in pharmacies and online health websites worldwide. Over-the-counter drugs are generally taken off the shelf. OTC drugs also include dietary supplements which are intended to deliver desired nutrients to the body to increase the quantity of an individual’s diet.
In Egypt, although some form of subsidized healthcare to be introduced in the long run is expected, interest in OTCs is changing, with customers moving away from essential medicines like analgesics and into more evolved therapeutic categories like dermatological, digestives, and vitamins.
Market Drivers
Egypt’s OTC drug sector will continue to grow as rising health awareness and self-medication practices become more popular. Increasing awareness regarding health and willingness towards self-medication are key growth factors. Factors related to urbanization such as increasing pollution, and other lifestyle disorders and needs will also help drive the OTC sector in Egypt in the forecast period.
OTC medicines are especially helmed by low-income households and people without health insurance. With customers moving away from essential medicines like analgesics, into more evolved therapeutic categories like dermatological, digestives, and vitamins, interest in OTCs is changing. Due to this development, the OTC market will be well-placed to take advantage of Egypt’s growing middle class and increasingly affluent population over the medium to long term, despite the dominance of prescription medicines.
The OTC healthcare market, despite its relatively large size, suffers from an absence of advertising and consumer-orientated marketing.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt Telemedicine Market Report 2022 to 2030Insights10
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Report Overview
The China Telemedicine market size stood at around $ 19.5 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of xx% during the forecast period.
The penetration of Telemedicine in china was maintaining an increment of 6.6% over the years and with the Covid-19 outbreak the penetration show a gradual rise of 2% among the population of china which is expected to increase at a much higher rate in the following years. The market is primarily focused on the age group below 35 but they are working on compatibility and operability to cover middle aged and elderly age groups.
Market Drivers
The internet penetration and inclusion of 5G mobile technology contributed vastly for the development of telemedicine market in china. The uneven distribution and development of advanced healthcare infrastructure across the Chinese geography is one of the prime factors which caused the Chinese population of central and western region to shift to telemedicine. Massive Covid-19 infection and the lockdown has caused a large population to opt for telemedicine and is expected to register a CAGR of 23% by 2026. Also, the low physician to citizen ratio contributes to the greater adoption of telehealth in china.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Egyptian contraceptive market will grow as a result of rising awareness of sexual health in Egypt. Long-lasting vaginal rings and fertility-tracking apps are some of the new contraceptive innovations used in Egypt. The market is segmented by drug type, medical devices, and end users. To get a detailed report, contact us at - info@insights10.com
Germany Physiotherapy Market Report 2022 to 2030Insights10
Germany's physiotherapy market analysis projects the growth of the physiotherapy market by $1.94 Bn in 2022 with a CAGR of 4.05% and is expected to reach $2.67 Bn in 2030. As physiotherapy concentrates more on rehabilitative and preventive treatments, the prevalence of cardiovascular and neurological disorders in geriatric populations are the main market drivers in the Germany physiotherapy market. The physiotherapy market is segmented by equipment, applications, and by end-users in Germany. Some leading companies in the physiotherapy market are BTL Industries, Performance Health, ITO Co. Ltd., and Enraf-Nonius B.V.
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt’s dental service market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
The dental service market caters to people’s oral hygiene and diseases needs. It consists of sales of dental services and related goods by entities (organizations, sole traders, and partnerships) that provide general dentistry, oral surgeries, and orthodontics and prosthodontic services. This industry comprises establishments of licensed health practitioners having a degree in D.M.D. – Doctor of Dental Medicine, D.D.S. – Doctor of Dental Surgery, or D.D.Sc. – Doctor of Dental Science.
Egypt has a fairly strong prevalence of dental issues. The country also increased the no. of dental colleges, leading to a rise in the no. of dental professionals in the country, although overall there still is a shortage of professionals relative to Egypt’s population size. In a study done in 2019 upon the children in the country, 74% of the total sample were found with dental caries.
Market Drivers
Oral hygiene awareness is one of the major contributors to market growth in the overall oral care/oral hygiene market through efforts made by dentists as well as key players in the market. These stakeholders conduct various seminars and programs to increase awareness of dental hygiene and demonstrate newly launched and technologically advanced products. This helps players to showcase their product portfolio, thereby raising the adoption of oral care products.
Rising demand for cosmetic dentistry has also set the market trajectory to rise in the forecast period. Further, the aging population, which has relatively higher dental care needs, is rapidly rising in Egypt and will boost the services market in the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Global Clinical Trial Patient Recruitment Services Market Analysis Sample ReportInsights10
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. To get a detailed report, contact us at - info@insights10.com
Egypt’s OTC drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Over-the-counter drugs are sold to the customer without a prescription from the doctor. They are typically used for minor health problems and are available at local pharmacies and shops. They are safe and effective when consumed according to the physician’s directions. OTC drugs can be readily available in pharmacies and online health websites worldwide. Over-the-counter drugs are generally taken off the shelf. OTC drugs also include dietary supplements which are intended to deliver desired nutrients to the body to increase the quantity of an individual’s diet.
In Egypt, although some form of subsidized healthcare to be introduced in the long run is expected, interest in OTCs is changing, with customers moving away from essential medicines like analgesics and into more evolved therapeutic categories like dermatological, digestives, and vitamins.
Market Drivers
Egypt’s OTC drug sector will continue to grow as rising health awareness and self-medication practices become more popular. Increasing awareness regarding health and willingness towards self-medication are key growth factors. Factors related to urbanization such as increasing pollution, and other lifestyle disorders and needs will also help drive the OTC sector in Egypt in the forecast period.
OTC medicines are especially helmed by low-income households and people without health insurance. With customers moving away from essential medicines like analgesics, into more evolved therapeutic categories like dermatological, digestives, and vitamins, interest in OTCs is changing. Due to this development, the OTC market will be well-placed to take advantage of Egypt’s growing middle class and increasingly affluent population over the medium to long term, despite the dominance of prescription medicines.
The OTC healthcare market, despite its relatively large size, suffers from an absence of advertising and consumer-orientated marketing.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt Telemedicine Market Report 2022 to 2030Insights10
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Report Overview
The China Telemedicine market size stood at around $ 19.5 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of xx% during the forecast period.
The penetration of Telemedicine in china was maintaining an increment of 6.6% over the years and with the Covid-19 outbreak the penetration show a gradual rise of 2% among the population of china which is expected to increase at a much higher rate in the following years. The market is primarily focused on the age group below 35 but they are working on compatibility and operability to cover middle aged and elderly age groups.
Market Drivers
The internet penetration and inclusion of 5G mobile technology contributed vastly for the development of telemedicine market in china. The uneven distribution and development of advanced healthcare infrastructure across the Chinese geography is one of the prime factors which caused the Chinese population of central and western region to shift to telemedicine. Massive Covid-19 infection and the lockdown has caused a large population to opt for telemedicine and is expected to register a CAGR of 23% by 2026. Also, the low physician to citizen ratio contributes to the greater adoption of telehealth in china.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Egyptian contraceptive market will grow as a result of rising awareness of sexual health in Egypt. Long-lasting vaginal rings and fertility-tracking apps are some of the new contraceptive innovations used in Egypt. The market is segmented by drug type, medical devices, and end users. To get a detailed report, contact us at - info@insights10.com
Germany Physiotherapy Market Report 2022 to 2030Insights10
Germany's physiotherapy market analysis projects the growth of the physiotherapy market by $1.94 Bn in 2022 with a CAGR of 4.05% and is expected to reach $2.67 Bn in 2030. As physiotherapy concentrates more on rehabilitative and preventive treatments, the prevalence of cardiovascular and neurological disorders in geriatric populations are the main market drivers in the Germany physiotherapy market. The physiotherapy market is segmented by equipment, applications, and by end-users in Germany. Some leading companies in the physiotherapy market are BTL Industries, Performance Health, ITO Co. Ltd., and Enraf-Nonius B.V.
This report presents a strategic analysis of the Indian Dermatology
Therapeutics market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends
and insights, growth and demand drivers, challenges & future outlook,
etc. This is one of the most comprehensive reports about the Indian
Dermatology Therapeutics Market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Egypt’s dental service market size was valued at USD xx billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of xx% from 2019 to 2028.
The dental service market caters to people’s oral hygiene and diseases needs. It consists of sales of dental services and related goods by entities (organizations, sole traders, and partnerships) that provide general dentistry, oral surgeries, and orthodontics and prosthodontic services. This industry comprises establishments of licensed health practitioners having a degree in D.M.D. – Doctor of Dental Medicine, D.D.S. – Doctor of Dental Surgery, or D.D.Sc. – Doctor of Dental Science.
Egypt has a fairly strong prevalence of dental issues. The country also increased the no. of dental colleges, leading to a rise in the no. of dental professionals in the country, although overall there still is a shortage of professionals relative to Egypt’s population size. In a study done in 2019 upon the children in the country, 74% of the total sample were found with dental caries.
Market Drivers
Oral hygiene awareness is one of the major contributors to market growth in the overall oral care/oral hygiene market through efforts made by dentists as well as key players in the market. These stakeholders conduct various seminars and programs to increase awareness of dental hygiene and demonstrate newly launched and technologically advanced products. This helps players to showcase their product portfolio, thereby raising the adoption of oral care products.
Rising demand for cosmetic dentistry has also set the market trajectory to rise in the forecast period. Further, the aging population, which has relatively higher dental care needs, is rapidly rising in Egypt and will boost the services market in the forecast period.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Global Clinical Trial Patient Recruitment Services Market Analysis Sample ReportInsights10
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Egypt's connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application.
To get a detailed report, contact us at - info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Japan telemedicine market size stood at around USD 220 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Modern ICTs are revolutionizing how individuals communicate with each other, seek and exchange information, and enriching their lives. These technologies have great potential to help address modern health issues. These recent advancements in, and increasing availability and utilization of, ICTs have been creating new possibilities for health care service and delivery. The replacement of analogue forms of communication with digital methods, combined with a rapid drop in the cost, have sparked wide interest in the application of telemedicine, and have enabled health care organizations to envision and implement new and more efficient ways of providing care. The introduction and popularization of the Internet have further accelerated the pace of ICT advancements, thereby expanding the scope of telemedicine to encompass Web-based applications (e.g. e-mail, teleconsultations and conferences via the Internet etc.) and multimedia approaches (e.g. digital imagery and video etc.)
Market Drivers
Several factors are contributing to the rapid rise of telehealth companies as the sector looks beyond tele stroke, remote patient monitoring, and other routine services. Specialized fields are starting to invest in telemedicine apps and software programs. New features like Artificial Intelligence, predictive analytics, and automated data collection are being used to lower the cost of care, improve patient engagement and accessibility. Regulatory agencies are also adopting the idea of digital healthcare, opening the door for new companies to capitalize on this trend.
Type of Services
Telemedicine services are further sub-classified into telemonitoring, tele-consulting, and tele-education. The telemonitoring segment is expected to grow over the forecast period owing to the increasing base of geriatric population requiring home assistance for care delivery. The Tele-consulting segment is anticipated to be the lucrative segment over the forecast period owing to the rising initiatives by the government for telehealth implementation projects and high demand for video conferencing solutions.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Egypt anti-aging market is expected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The consistent demand for anti-wrinkle products for aging people across Egypt is driving the growth of the market. Alma Lasers and Beiersdorf are the key players in the market. To get a detailed report, contact us at - info@insights10.com
India Ophthalmology Therapeutics Market Report 2022 to 2030Insights10
Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028).
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
Key AI Trends Propelling a Sea Change in Post-pandemic careInsights10
Care delivery models are shifting paradigm shifts with the advent of novel technology solutions across the healthcare and life sciences industry. AI and ML applications are partly to take credit for this transformation which has facilitated the delivery of high-quality care services more conveniently. To get a report in detail, contact us at - info@insights10.com
This report presents a strategic analysis of the Canada Dermatology
Prescription market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends and
insights, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Canada
Dermatology Prescription market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Malaysia Healthcare Diagnostics Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Malaysia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Africa Physiotherapy Market Sample ReportInsights10
This report presents a strategic analysis of the South Africa Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Egypt Home Healthcare Market Analysis Sample ReportInsights10
The Egypt Home Healthcare Market is witnessing lucrative growth opportunities as the demand for high-quality home healthcare services increase in Egypt. The rising geriatric population and associated lifestyle diseases in Egypt are primarily responsible for the growth of the market. Alrazy Group and Manzil Home Health Services are some of the major players in the Egypt home healthcare market. To get a detailed report, contact us at - info@insights10.com
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Germany Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies, regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Germany Dental Care Market, offering unmatched value, accuracy, and expert insights.
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Egypt's connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application.
To get a detailed report, contact us at - info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
India Physiotherapy Market Report 2022 to 2030Insights10
India's physiotherapy market size was valued at $0.96 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.85% from 2022 to 2030 and will reach $1.9 Bn in 2030. This market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The key players are BTL Industries. Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.
The Canadian dermatological therapeutics market size stood at around USD 1.65 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The Canadian skincare industry is growing tremendously at xx% from 2015-2019 and is forecasted to grow by xx% (2020-2028), as more Canadians are investing in their skincare and the market is driven by an aging population looking for solutions to maintaining healthy skin and younger. Technological advancements and the increasing prevalence of skincare are anticipated to fuel the growth.
Market Drivers
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups. The Growing demand for anti-aging products and innovative and eco-friendly packaging designs are attributing to the market growth in the country. Canada’s skin allergy market is forecasted to grow by 3.9% over the 2020-2027 period. The extensive presence of online retail channels is also influencing sales of cosmetics in the country. The collective incidence of dermatological diseases and increasing levels of awareness-related disease progression, Etiology, and available therapies are leading to the high growth of dermatological therapeutics.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Japan telemedicine market size stood at around USD 220 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Modern ICTs are revolutionizing how individuals communicate with each other, seek and exchange information, and enriching their lives. These technologies have great potential to help address modern health issues. These recent advancements in, and increasing availability and utilization of, ICTs have been creating new possibilities for health care service and delivery. The replacement of analogue forms of communication with digital methods, combined with a rapid drop in the cost, have sparked wide interest in the application of telemedicine, and have enabled health care organizations to envision and implement new and more efficient ways of providing care. The introduction and popularization of the Internet have further accelerated the pace of ICT advancements, thereby expanding the scope of telemedicine to encompass Web-based applications (e.g. e-mail, teleconsultations and conferences via the Internet etc.) and multimedia approaches (e.g. digital imagery and video etc.)
Market Drivers
Several factors are contributing to the rapid rise of telehealth companies as the sector looks beyond tele stroke, remote patient monitoring, and other routine services. Specialized fields are starting to invest in telemedicine apps and software programs. New features like Artificial Intelligence, predictive analytics, and automated data collection are being used to lower the cost of care, improve patient engagement and accessibility. Regulatory agencies are also adopting the idea of digital healthcare, opening the door for new companies to capitalize on this trend.
Type of Services
Telemedicine services are further sub-classified into telemonitoring, tele-consulting, and tele-education. The telemonitoring segment is expected to grow over the forecast period owing to the increasing base of geriatric population requiring home assistance for care delivery. The Tele-consulting segment is anticipated to be the lucrative segment over the forecast period owing to the rising initiatives by the government for telehealth implementation projects and high demand for video conferencing solutions.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
The Egypt anti-aging market is expected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The consistent demand for anti-wrinkle products for aging people across Egypt is driving the growth of the market. Alma Lasers and Beiersdorf are the key players in the market. To get a detailed report, contact us at - info@insights10.com
India Ophthalmology Therapeutics Market Report 2022 to 2030Insights10
Indian Ophthalmology Therapeutics Market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX% during the forecast period (2019-2028).
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
Key AI Trends Propelling a Sea Change in Post-pandemic careInsights10
Care delivery models are shifting paradigm shifts with the advent of novel technology solutions across the healthcare and life sciences industry. AI and ML applications are partly to take credit for this transformation which has facilitated the delivery of high-quality care services more conveniently. To get a report in detail, contact us at - info@insights10.com
This report presents a strategic analysis of the Canada Dermatology
Prescription market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market
value, dynamics, segmentation, characteristics, main players, trends and
insights, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Canada
Dermatology Prescription market, offering unmatched value, accuracy
and expert insights.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Malaysia Healthcare Diagnostics Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Malaysia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Africa Physiotherapy Market Sample ReportInsights10
This report presents a strategic analysis of the South Africa Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Egypt Home Healthcare Market Analysis Sample ReportInsights10
The Egypt Home Healthcare Market is witnessing lucrative growth opportunities as the demand for high-quality home healthcare services increase in Egypt. The rising geriatric population and associated lifestyle diseases in Egypt are primarily responsible for the growth of the market. Alrazy Group and Manzil Home Health Services are some of the major players in the Egypt home healthcare market. To get a detailed report, contact us at - info@insights10.com
The Indian Home Healthcare market size was valued at USD 5.2 Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 19.2% from 2019 to 2028.
The increasing incidence of chronic diseases and the need for better primary and postoperative care has enhanced market growth Homecare in India. According to the World Health Organization (WHO), chronic and lifestyle diseases are expected to increase by XX% in India. Due to COVID-19 Pandemic, home healthcare services are considered to be safer and cost-effective alternative to hospital services for non-emergent cases. Home Healthcare in India is growing by 15-19% a year to touch $11-13 billion by 2025 from $5.4 billion.
Market Drivers
To avoid risk of getting infected, lack of personal care, to reduce the unnecessary hospital visits and high hospitalization costs are the major drivers that consumers are looking at home healthcare as the emerging solution. As the prevalence of lifestyle diseases, rising demand for quality and affordable care the need of Home Healthcare has increased. Home Healthcare Provides ICU services at 50% cheaper rate than the hospitals. ICU facility at Home with equipment and medical expertise ranges between Rs 7,500 to Rs 10,000 a day.
Type of Home Healthcare Services
The Home Healthcare market is further segmented by type of service into Physician/Primary Care, Nursing Care, Physical Occupational and Speech Therapy, Nutritional Support, Hospice & Palliative, Other Skilled Homecare Services. Primary care and Nursing care is dominating homecare services covering around XX% of Homecare Market in India.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Germany Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies, regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Germany Dental Care Market, offering unmatched value, accuracy, and expert insights.
Similar to Egypt Contraceptives Market Analysis (20)
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Patient - First Health With Generative AIInsights10
Patient-First Health With Generative AI Learn about the groundbreaking potential of #GenerativeAI in patient engagement, including its three broad categories of use cases. Understand why this innovation is poised to revolutionize patient interaction with their health and the crucial steps stakeholders must take to bring it to fruition. Don't miss this essential read by Insights10 for anyone passionate about the intersection of AI and healthcare! To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/42OOgWa
Vietnam In-Vitro Fertilization (IVF) Service Market AnalysisInsights10
This report presents a strategic analysis of Vietnam In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Turkey nutrition and supplements market will reach a value of $6.08 Mn from $3.05 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The nutritional supplements market in Turkey is primarily dominated by local players such as Form Labs, Hülya Şahin, and Solgar. To get a detailed report, contact us at - info@insights10.com
Spain Artificial Intelligence (AI) in Healthcare Market AnalysisInsights10
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. To get a detailed report, contact us at - info@insights10.com
Japan Nutritional Supplements Market Analysis.pdfInsights10
By 2030, it is anticipated that the Japan Nutrition and Supplements market will reach a value of $47.25 Bn from $23.71 Bn in 2022, growing at a CAGR of 9% during 2022-30. The market is primarily dominated by local players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto.To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Australian dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha Pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. To get a detailed report, contact us at - info@insights10.com
Australia Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. To get a detailed report, contact us at - info@insights10.com
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. To get a detailed report, contact us at - info@insights10.com
South Africa Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the South Africa Nutrition and Supplements market will reach a value of $xx Bn from $2.48 Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. To get a detailed report, contact us at - info@insights10.com
Bulgaria Over The Counter (OTC) Pharmaceuticals Market AnalysisInsights10
Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. The Radiotherapy Therapeutics Market in Japan is dominated by a few domestic players such as Hitachi, Mitsubishi Electric Corporation, and IHI Corporation. The radiotherapy market in Japan is segmented into different types, technologies, procedures, applications, and end-users.
To get a detailed report, contact us at - info@insights10.com
Generative AI Startup Scenario in India 2023Insights10
Let's see how Generative AI is revolutionizing Indian Healthcare. Imagine AI generating personalized treatment plans, predicting disease outbreaks, or even designing life-saving drugs. This isn't sci-fi, it's the thriving reality of India's Generative AI healthcare startups in 2023.
Startups like Tricuss, Niramai, PharmEasy, Qure.ai, and HealthifyMe are harnessing the power of generative models to tackle critical healthcare challenges.
Global Breast Cancer Therapeutics Market ArticleInsights10
With an increase in breast cancer cases worldwide and rising investments in the research and development projects for breast cancer treatment, the Global breast cancer therapeutics market is expected to grow from $18.2 Bn in 2022 to $48.04 Bn in 2030 with a CAGR of 12.9% for the year 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. To get a detailed report, contact us at - info@insights10.com
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
3. This report presents a strategic analysis of the Egyptian
Contraceptives market and a forecast for its development in the
medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, characteristics, main players,
trends and insights, growth and demand drivers, challenges & future
outlook, etc. This is one of the most comprehensive reports about the
Egyptian Contraceptives market, offering unmatched value, accuracy
and expert insights.
4. The report is prepared
using a proven
methodology and
insightful research.
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make smarter
business and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more.
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works.
Easy to read
What kind of data is presented
in this Report?
This report presents data, which is:
5. 5 A Sample Report on Egypt Contraceptive Market I Confidential
Table of Contents
1. Methodology and Scope…………………………………………………………………….…………………………………………………..…..08
1.1 Research Methodology
1.2 Analysis Methodology
1.3 Research Approach
1.4 Key benefits for stakeholders
2. Egypt Contraceptive Market Overview………………………………………………………………..…………………………………....…....14
2.1 Background
2.2 Introduction
2.3 Market size and forecast
3. Market Growth Drivers and Restraints …………………………………………………………………….…………………………………….18
3.1 Market Growth Drivers
3.1.1 Growing need of population control
3.1.2 Implementation of pregnancy controlling activities
3.1.3 High effectiveness and convenience
3.1.4 Raising rates of STDs
3.1.5 Government Initiatives
3.1.6 Raising awareness level among users
6. 6 A Sample Report on Egypt Contraceptive Market I Confidential
Table of Contents (continued)
3.2 Market Restraints
3.2.1 Misconceptions about contraceptives
3.2.2 Lack of Awareness
4. Major Types of Contraceptive Methods…..…………………………………………………………………………………..………………..27
4.1 Barrier Methods
4.2 Short-Acting Hormonal Methods
4.3 Long-Acting Hormonal Methods
4.4 Sterilization
4.5 Fertility Awareness Methods
5. Contraceptive Market Segmentation………………………..…………………………………………………………………..……….…….30
5.1 By Drug Type
5.2 By Medical Devices
5.3 By End Users
7. 7 A Sample Report on Egypt Contraceptive Market I Confidential
Table of Contents (continued)
6. Contraceptive Major Products Market Share…………………………………………………………...…………..….......…..35
6.1 Market Analysis, Insights and Forecast - By Revenue
7. Competitive Landscape……………………………………………………………………………………………………………...37
7.1 Major Players
7.2 Products in Pipeline
8. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………...42
8.1 EPICO Pharmaceuticals
8.2 Pfizer
8.3 dkt International
8.4 Glaxosmithkline
8.5 SEDICO Pharmaceuticals
9. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………53
9.1 Regulatory Framework of Egyptian Drug Market
10. Factors Driving Future Growth……………………………………………………………………………………………….……58
8. A Sample Report on Egypt Contraceptive Market
1. Methodology and Scope
9. 9 A Sample Report on Egypt Contraceptive Market I Confidential
1.1 Research Methodology
Insights 10’s research methodology delves deep into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conducted extensive data mining, referring to verified data sources such as independent studies,
government and regulatory published material, technical journals, trade magazines, and paid data sources
For forecasting, the following parameters were considered:
Market drivers and restraints along with their current and expected impacts
Technological scenario and expected developments
End use industry trends and dynamics
Trends in the consumer behavior
Regulatory scenario and expected developments
Current capacity and expected capacity additions up to 2030
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the
expected market growth rate
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
All our estimates and forecasts were verified through exhaustive primary research with the Key Industry Participants (KIPs)
10. 10 A Sample Report on Egypt Contraceptive Market I Confidential
1.2 Analysis Methodology
• Final Market Size Break-up to Rest of
Segmentation i.e., Product and Services,
Type, Specialty, Delivery Mode and
Geography, etc
• Arriving at the Market Size of each Segment
• Data Validation with Primary Interviews
• Final Market Size
• Validation from Primary Interview
• Summation of Revenue Generated from
Companies to Arrive at Total Market Size
• Revenue Generated by Products and
Services offered by Companies
Top Down Analysis
Bottom-up Analysis
11. 11 A Sample Report on Egypt Contraceptive Market I Confidential
1.3 Research Approach
The data presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Collection
• Primary Interviews (Industry Participants,
Outside experts)
• Secondary Data
Company Reports and Publications,
Government Data, Financial Reports of Key
Industry Players, Press Releases, Scientific
and Industry Publications and Whitepapers
Market Data Analysis &
Statistical Model
• Market Trends
• Market Sizing and Analysis
• Data Triangulation & Validation
Market Trends such as Drivers, Restraints,
Opportunities, Challenges. An intensive
cross-verification and validation process
Interpretation and
Presentation
• Analysis & Interpretation
• Insights
• Presentation & Reporting
The information gathered is then analyzed
and synthesized. The market research
report is presented in different forms such
as charts by using a scientific approach for
easy understanding
12. 12 A Sample Report on Egypt Contraceptive Market I Confidential
1.4 Key Benefit for Stakeholders from this report
The study provides an in-depth analysis of the Egypt Contraceptive Drug Market with current trends and future estimations to
elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
13. “Egypt is not just a sun-soaked paradise
defined by pyramids and tombs, or a
hotbed for political turmoil and revolution.
It’s also a vibrant and growing market for
Pharmaceuticals & Contraceptive
Products.”
14. A Sample Report on Egypt Contraceptive Market
2. Egypt Contraceptive Market Analysis :
Market Overview
15. 15 A Sample Report on Egypt Contraceptive Market I Confidential
2.1 Background
Egypt is the most populous country in the Middle East and the third most populous country in Africa. Fertility levels are the
main determinant of population growth.
In 1965, Egypt became the first country in the Arab world to launch an official family planning program.
Family planning in Egypt was supported by large international investments, particularly from the U.S. Agency for International
Development (USAID), which became the program’s largest foreign donor.
Despite the program’s early establishment, political support was inconsistent and fertility remained high until the 1980s. In 2014,
Egypt’s Demographic and Health Survey (EDHS) documented an increase in the total fertility rate (TFR) to 3.5, up from a low of
3.0 recorded by the 2008 EDHS, reversing a 25-year trend of fertility decline.
Between 2008 and 2014 the level of contraceptive use dropped slightly, from 60% to 58%. The proportion of IUD users
declined from 36% to 30%, and the proportion of pill users increased from 12% to 16%.
While all are considered effective modern methods, there is evidence that women using the pill and other short-acting
modern methods have shorter birth intervals, by choice or by contraceptive failure, compared to those using IUDs
IUD - intrauterine device
16. 16 A Sample Report on Egypt Contraceptive Market I Confidential
2.2 Introduction
Contraceptive methods have a range of benefits other than their primary purpose of
pregnancy prevention. Contraception reduces pregnancy-related morbidity and
mortality, reduces the risk of developing certain reproductive cancers, and can be
used to treat many menstrual related symptoms and disorders.
11% of women (15-49 years) are pregnant or have had a live birth in Egypt.
One fifth of non-first births were born within 24 months of a prior birth interval.
Contraceptive prevalence rate is 59% and desired fertility among ever-married
women (15-49) is still at three children.
The Strategic National Population Plan 2015-2030 in Egypt has called for
accelerated efforts to reduce the TFR to 2.4 births per woman by the year 2030. In
order to achieve this target, the family planning program must maintain good quality
of family planning service provision and ensure that attitudes favorable to the use
and acceptance of contraception are maintained. However, this target should be
viewed as ambitious, considering the rising cost of ensuring contraceptive security
as a result of the large increase in Egypt’s population. IUD - intrauterine device
17. 17 A Sample Report on Egypt Contraceptive Market I Confidential
Egypt Contraceptive Market Size $Mn) 2022-2030F
2.3 Market Size & Forecast
Egypt Contraceptive market size stood at around USD XX
million in 2021 and is projected to reach USD XX million by
2030, exhibiting a CAGR of around XX.X% during the
forecast period
Egypt's Contraceptive use will increase as the sector will
continue to grow due to rising awareness on sexual health
The Govt. of Egypt is committed to safeguarding the health
of women and girls in the country and mitigating the rate of
its population growth by expanding its contraceptive
programs and improving the quality of services to attract
new users while expanding contraceptive methods choice
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Key Analysis
$XX Mn
$XX Mn
18. A Sample Report on Egypt Contraceptive Market
3. Egypt Contraceptive Market Analysis :
Growth Drivers and Growth Restraints
19. 19 A Sample Report on Egypt Contraceptive Market I Confidential
3.1 Market Growth Drivers
Market
Restraints
The growing need for population
control
Rising rates of STDs
Rising awareness levels among
users
High effectiveness and
convenience
Market
Drivers
Government Incentives
Implementation of pregnancy
controlling activities
20. 20 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers
1. The growing need for population control
Sample
With the rapid growth of the Egyptian population from 20.8 to 100 million inhabitants in the past 50 years, strenuous efforts
have been made to promote maternal and child health through family planning programs.
Sample
21. 21 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers (continued)
The family programs programs empower families to make informed decisions on the number of children and interval
between children they want and to reduce unintended pregnancies. This will continue to boost the market for
contraceptives in Egypt.
Implementation of activities aimed at controlling unwanted pregnancy associated healthcare spending
2. Implementation of pregnancy controlling activities
Sample
22. 22 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers (continued)
3. High effectiveness and convenience
Due to high effectiveness and convenience, oral contraceptive pills are the most common form of reversible contraception
in the developed economies, followed by condoms, which are considered to be the most lucrative segment in the overall
contraceptive devices market.
Sample
Sample
23. 23 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers (continued)
4. Rising rates of STDs
Sample
Rising rates of STDs have made people aware of contraceptives and the market is expected to sustain and grow through the
forecast period.
Increasing incidence of STDs is of the highest impact rendering drivers of this industry.
24. 24 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers (continued)
5. Government Incentives
Sample
Egypt's health minister launched Operation Lifeline last month, a plan to reduce the birth rate to 2.4 million by 2030 and save
the government up to 200 billion Egyptian pounds ($11.3 billion).
The health ministry said it would deploy 12,000 family planning advocates to 18 rural provinces but gave no details of how it
would attract more women to the program.
25. 25 A Sample Report on Egypt Contraceptive Market I Confidential
Market Growth Drivers (continued)
6. Rising awareness levels among users
Sample
Egypt is attempting to educate people in rural areas about birth control and family planning in order to slow the rate of
population growth that President Abdel Fattah al-Sisi has described as a threat to national development.
Egypt has also recently committed to Family Planning 2020, a global movement that supports women’s and girls’ rights to
freely decide when and how many children they want to have.
26. 26 A Sample Report on Egypt Contraceptive Market I Confidential
Misconceptions about contraceptives
3.2 Market Restraints
Misconceptions about contraceptives still exist
and this could factor in restraining the market
growth in the country.
A number of Egyptian couples are not practicing
contraception.
Three main barriers that Egyptian women most
commonly cite as reasons for not using
contraception are concerns about side
effects/health problems, concerns about having
to have a vaginal examination, and difficulty in
getting the money to pay for contraception
Lack of awareness
The Contraceptive market development has
been hampered by factors such as the lack of
healthcare awareness among patients
Sample
Sample
27. A Sample Report on Egypt Contraceptive Market
4. Egypt Contraceptive Market Analysis:
Major Contraceptive Methods
28. 28 A Sample Report on Egypt Contraceptive Market I Confidential
Major Contraceptive Methods
Barrier Methods Short-Acting
Hormonal Methods
Short acting hormonal methods
include the pill, the patch, and the
NuvaRing and prevent pregnancy
by interfering with ovulation and
fertilization of the egg.
These methods can be
combined hormonal, containing
both estrogen and progestin, or
progestin only methods
• Barrier methods of birth control
act as barriers to keep sperm
from reaching the egg.
• Some barrier methods also
protect against sexually
transmitted infections (STIs). A
few barrier methods
(spermicide, condom, and
sponge) can be bought in most
drugstores
Long-acting reversible
contraceptives (LARCs) are the
most effective methods of birth
control.
LARCs include the copper
Paragard IUD, the hormonal
(progesterone) Mirena IUD, and
the hormonal contraceptive
implant.
Long-Acting Hormonal
Methods
29. 29 A Sample Report on Egypt Contraceptive Market I Confidential
Major Contraceptive Methods
Sterilization
Fertility Awareness
Methods
The fertility awareness method
(FAM) is a natural family
planning strategy that women
can use to help prevent
pregnancy. It involves tracking
your natural cycle of fertility
and your menstrual cycle,
developing a better awareness
of your body, and using a
variety of non-pharmaceutical
methods to detect ovulation
• Sterilization is a permanent
method of birth control.
Sterilization procedures for
women are called tubal ligation.
• The procedure for men is
called vasectomy. How does
tubal ligation work to prevent
pregnancy? Tubal ligation
closes off the fallopian tubes.
30. A Sample Report on Egypt Contraceptive Market
5. Egypt Contraceptive Market Analysis :
Market Segmentation
31. 31 A Sample Report on Egypt Contraceptive Market I Confidential
Snapshot of Contraceptive Market Segmentation
Market Segmentation
By Medical Devices
By Drug Type
Hospitals
Contraceptive
Diaphragms
Contraceptive Sponges
Female Contraceptive
Devices
Contraceptive Pills
Topical Pills
Contraceptive
Injectables
Others
Subdermal Contraceptive
Implants
Contraceptive Patches
Male Contraceptive
Devices
By End-Users
Home Care
Clinics & Ambulatory
Surgical Centres
Non-surgical Permanent
Contraceptive devices
Retail Pharmacies
32. 32 A Sample Report on Egypt Contraceptive Market I Confidential
Based on drug type the market is segmented into
Contraceptive Pills, Topical Pills, Contraceptive
Injectables, and Others which include contraceptives gels,
jellies, and creams
5.1 Market Segmentation: By Drug Type
Egypt Contraceptive Market Share By Drug Type 2022
Key Insights
Contraceptive Pills Topical Pills Contraceptive Injectables
Others Ophthalmic Products
33. 33 A Sample Report on Egypt Contraceptive Market I Confidential
5.2 Market Segmentation: By Medical Devices
Egypt Contraceptive Market Share By Medical Devices
2022
Male Contraceptive Devices, Female Contraceptive
Devices, Contraceptive Sponges, Contraceptive
Diaphragms, Subdermal Contraceptive Implants,
Contraceptive Patches, Non-surgical Permanent
Contraceptive devices
Key Insights
Male Contraceptive Devices Female Contraceptive Devices
Contraceptive Sponges Contraceptive Diaphragms
Subdermal Contraceptive Implants Contraceptive Patches
Non-surgical Permanent Contraceptive devices
34. 34 A Sample Report on Egypt Contraceptive Market I Confidential
5.3 Market Segmentation: By End Users
Egypt Contraceptive Market Share by End Users 2022
By end-users, the Contraceptives market is segmented
into Hospitals, Homecare, Clinics & Ambulatory Surgical
Centers, and Retail Pharmacies
Pharmacies and Hospitals remain the primary point of
access for contraceptive services, and the distribution of
consumer contraceptives are permitted through
pharmacies, clinics and hospitals
Key Insights
Hospitals Homecare
Clinics & Ambulatory Surgical Centres Retail Pharmacies
35. A Sample Report on Egypt Contraceptive Market
6. Egypt Contraceptive Market Analysis :
Contraceptive Major Products Market Share
36. 36 A Sample Report on Egypt Contraceptive Market I Confidential
TOP BRANDS IN EGYPT CONTRACEPTIVE
MARKET
6.1 Major Contraceptive Products Market Share
Key Insights
Egypt Contraceptive Major Products
Market Share
Brand 1 Brand 2 Brand3 Brand 4
37. A Sample Report on Egypt Contraceptive Market
7. Egypt Contraceptive Market Analysis :
Competitive Landscape
38. 38 A Sample Report on Egypt Contraceptive Market I Confidential
7.1 Major Players
39. 39 A Sample Report on Egypt Contraceptive Market I Confidential
Major Players Revenue (Current and Forecast)
2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
EPICO
Pharmaceutical
XX - - - - - - - -
Pfizer XX - - - - - - - -
dkt international XX - - - - - - - -
Glaxosmithkline XX - - - - - - - -
SEDICO
Pharmaceuticals
XX - - - - - - - -
Major Market Revenue of Egypt Contraceptive ($Bn)
40. 40 A Sample Report on Egypt Contraceptive Market I Confidential
Key Players by Revenue Growth and Market Share
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
EPICO Pharmaceuticals
Pfizer
dkt international
Glaxosmithkline
SEDICO Pharmaceuticals
Key Players Egypt Contraceptive ($Bn)
Revenue Market Share Growth
41. 41 A Sample Report on Egypt Contraceptive Market I Confidential
7.2 Products in Pipeline
Darebio company has pipeline
contraceptive such as Ovaprene
Hormone- Free, Monthly Contraception,
which is pivotal phase 3 study expected
to commence in 2022
Content
Content
42. A Sample Report on Egypt Contraceptive Market
8. Key Company Profiles
43. 43 A Sample Report on Egypt Contraceptive Market I Confidential
8.1 EPICO Pharmaceuticals
Company Profile
Company Name: EPICO Pharmaceuticals
Year of Establishment: 1980
Headquarter: Egypt
Revenue: $21 Million.
Website: https://www.eipico.com
Sample
44. 44 A Sample Report on Egypt Contraceptive Market I Confidential
EPICO Pharmaceuticals (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
45. 45 A Sample Report on Egypt Contraceptive Market I Confidential
Sample
Company Name: Pfizer
Year of Establishment: 1849
Headquarter: New York, United Kingdom
Revenue: $81.28 Bn
Website: https://www.pfizer.com
Company Profile
8.2 Pfizer
46. 46 A Sample Report on Egypt Contraceptive Market I Confidential
Pfizer (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
47. 47 A Sample Report on Egypt Contraceptive Market I Confidential
Sample
Company Name: dkt international
Year of Establishment: 1989
Headquarter: Washington, United States
Revenue: $250.9
Website: https://www.dktinternational.org/
Company Profile
8.3 dkt international
48. 48 A Sample Report on Egypt Contraceptive Market I Confidential
dkt international (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030)
XX
XX
Sample
1 2 3 4
49. 49 A Sample Report on Egypt Contraceptive Market I Confidential
8.4 Glaxo SmithKline
Company Profile
Company Name: Glaxo SmithKline
Year of Establishment: 2000
Headquarter: London, UK
Revenue: $42.11 Bn
Website: https://www.gsk.com/en-gb/home/
Sample
50. 50 A Sample Report on Egypt Contraceptive Market I Confidential
Glaxo SmithKline (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
51. 51 A Sample Report on Egypt Contraceptive Market I Confidential
Sample
Company Name: SEDICO Pharmaceutical
Year of Establishment: 1988
Headquarter: Egypt
Revenue: $31 million
Website: http://www.sedico.net
Company Profile
8.5 SEDICO Pharmaceutical
52. 52 A Sample Report on Egypt Contraceptive Market I Confidential
SEDICO Pharmaceutical (continued)
Breakdown of net revenue by segment, 2022
Analysis
Revenues ($Bn), 2022-2030
XX
XX
Sample
1 2 3 4
53. A Sample Report on Egypt Contraceptive Market
9. Healthcare Policy and Regulatory Landscape
54. 54 A Sample Report on Egypt Contraceptive Market I Confidential
9.1 Regulatory Framework of Egyptian Drug Market
55. 55 A Sample Report on Egypt Contraceptive Market I Confidential
The Egyptian Drug Authority (EDA) is the regulatory body, affiliated with the Ministry of Health, with authority over the
pharmaceutical industry.
Marketing authorization is not allocated to any product unless the necessary certificate of compliance is obtained from the
National Organization for Drug Control and Research (NODCAR) within the EDA.
According to the rules and regulations, combined oral contraceptives and progestin-only pills are supplied by trained
health providers. However, in general, the prevailing practice is for community pharmacies to provide hormonal
contraceptives without a prescription.
Abortion is legally possible only in cases of risk to the mother’s life or major fetal anomalies, and therefore access to drugs
for medical abortion is highly restricted and controlled
Regulatory Framework of Egyptian Drug Market
56. 56 A Sample Report on Egypt Contraceptive Market I Confidential
Programmes and Policies - Egyptian Contraceptive Market
57. 57 A Sample Report on Egypt Contraceptive Market I Confidential
Social, cultural, and religious norms in Egypt have sometimes caused family planning to be stigmatized. Reversing a more than
25-year pattern of declining fertility, the average number of children a woman has in her lifetime increased substantially
The Egyptian government, a recent commitment maker, is committed to protecting the health of its women and girls and slowing
the rate of population growth by expanding contraceptive programmes and improving service quality to attract new users while
expanding contraceptive method choice
FP2020 employs a set of quantitative metrics known as Core Indicators to track progress across 69 focus countries on an
annual basis. Estimates for the Core Indicators are produced annually by commitment countries via a network of Track20 M&E
officers based in government institutions
Improving the commodity supply chain management system of the Ministry of Health and Population (MoHP).
The introduction of the "Logo for Excellence" in family planning clinics recognized as centers of excellence in the provision of
quality services
Regulatory Framework of Egyptian Contraceptive Market
58. A Sample Report on Egypt Contraceptive Market
10. Future Driving Growth
59. 59 A Sample Report on Egypt Contraceptive Market I Confidential
Future Opportunities
Updating the national standards of practice according to recent WHO standards and build the capacity of service
providers at all levels
Developing a national five-year plan to forecast future needs, procure and distribute resources accordingly.
Sample
Implementing the recent ministerial decree for the Contraceptive Security Committee to secure the provision of
contraceptive commodities
Increasing collaboration with the curative sector, nongovernmental organizations, and the private sector by providing
national guidelines, training service providers on updated standards of practice, and providing FP services.
Sample
60. 60 A Sample Report on Egypt Contraceptive Market I Confidential
Egypt Contraceptive Drug Market is growing and
presents lucrative Strategic Recommendations
Developing a national five-year plan to forecast future
needs, procure and distribute resources accordingly.
Improving the quality of client counselling by updating
and widely disseminating FP counselling guidelines.
Improving the supervision system to monitor service
quality and connect it to the Health Insurance
System.
Integrating family planning services with other primary
health care services such as antenatal counselling
and post-partum care, vaccination, and follow-up
visits for healthy children.
Designing and carrying out operational research to
identify system gaps and implement appropriate
corrective actions.
Improving acceptance of FP services through national
campaigns, particularly in remote areas, by
increasing knowledge of sexual and reproductive
health and family planning.